Ignite Creation Date:
2024-05-06 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03130582
Status:
COMPLETED
Last Update Posted:
2017-04-28
First Post:
2017-04-22
Brief Title:
High-dose Etoposide Could Discriminate Patients With RefractoryRelapsed Lymphoma Benefit From APBSCT
Sponsor:
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine